Park Ha Biological Technology Co., Ltd. BYAH
2.77
(0.10)
(3.48%)
as of 25 Sep
- Market cap
- $6.5M
- P/E
- —
Follow BYAH
| Oct '25 | Oct '24 | Dec '23 | Oct '23 | Dec '22 | Oct '22 | Dec '17 | Oct '17 | Dec '16 | Oct '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/FCF ratio |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.68) | (0.25) | — | (0.25) | (0.25) | (0.25) | (0.25) | (0.25) | (0.25) | (0.25) |
EV/FCF |
(1.90) | (0.28) | — | (0.28) | (0.28) | (0.28) | (0.28) | (0.28) | (0.28) | (0.28) |
Quick Ratio |
2.34 | 1.33 | 0.00 | 1.43 | 1.43 | 1.43 | 1.09 | 1.09 | 1.33 | 1.33 |
Current Ratio |
2.92 | 1.87 | 0.00 | 1.75 | 1.75 | 1.75 | 1.09 | 1.09 | 1.33 | 1.33 |
Net Debt/EBITDA |
0.16 | (0.67) | 0.00 | (0.86) | (0.85) | (0.85) | 2.60 | 2.60 | (5.16) | (5.16) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 20.43% | 20.43% | 39.75% | 39.75% |
Debt/Equity |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.67 | 0.67 | 1.16 | 1.16 |
Asset Turnover |
0.56 | 1.04 | 0.00 | 1.09 | 1.09 | 0.00 | 0.25 | 0.18 | 0.20 | 0.18 |
Operating CF/Net income |
0.00 | 2.01 | (1.52) | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex/Depreciation |
(0.81) | (3.77) | (1.13) | (1.13) | — | — | — | — | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (885.83%) | 38.01% | 0.00% | 187.81% | (809.89%) | (54.88%) | 7,233.33% | (205.69%) | (94.39%) | (64.13%) | |
| (539.29%) | 20.94% | 25.51% | 37.62% | 37.62% | 0.09% | (11.98%) | (8.70%) | (6.36%) | (5.93%) | |
ROIC |
(7,284.30%) | 51.75% | 0.00% | 0.00% | 0.00% | 0.00% | (15.07%) | (15.07%) | (2.61%) | (2.61%) |
Return on Tangible Assets |
(644.88%) | 33.62% | 32.35% | 87.67% | 87.67% | 87.67% | (278.21%) | (278.21%) | (69.18%) | (69.18%) |
Average Days of Receivables |
89.33 | 226.69 | 0.00 | 110.77 | 110.77 | 110.77 | 62.43 | 62.43 | 38.73 | 38.73 |
Research and Development Expense of Revenue |
9.43% | 1.54% | — | 1.26% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
1,034.09% | 49.38% | 0.00% | 31.91% | 38.09% | 38.09% | 57.24% | 57.24% | 51.29% | 51.29% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
953.35% | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
34.30 | 38.11 | — | 39.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
1.17 | 15.37 | 0.00 | 2.02 | — | — | — | — | — | — |
Capex per Share |
(1.21) | (1.37) | 0.00 | (0.36) | — | — | — | — | — | — |
Free Cash Flow per Share |
(0.04) | 14.00 | 0.00 | 1.66 | — | — | — | — | — | — |
Cash per Share |
51.46 | 8.76 | — | 16.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
54.28 | 24.10 | — | 16.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | — | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
54.28 | 24.10 | — | 16.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
0.00 | 0.87 | (0.75) | 0.10 | — | — | — | — | — | — |
Working Capital |
3.62 | 1.32 | 1.48 | 0.93 | 0.93 | 0.93 | 56.00 | 56.00 | 256.00 | 256.00 |
Capital Expenditures |
(0.09) | (0.09) | (0.02) | (0.02) | — | — | — | — | — | — |
Net Current Asset Value |
3.54 | 1.27 | 1.48 | 0.92 | 0.92 | 0.92 | (597.00) | (597.00) | (1,056.00) | (1,056.00) |
EV/EBIT |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.04 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
(965.02%) | 20.09% | 0.00% | 34.65% | 34.65% | 34.65% | (47.59%) | (47.59%) | (32.48%) | (32.48%) |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.69 | 0.22 | 0.00 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(0.93%) | 41.71% | 0.00% | 4.30% | (1.89%) | (1.89%) | (1.46%) | (1.46%) | (1.09%) | (1.09%) |
Accounts Receivable Turnover |
2.41 | 1.61 | 0.00 | 3.30 | 3.30 | 0.06 | 5.85 | 6.33 | 9.42 | 8.46 |
Accounts Payable Turnover |
7.89 | 1.77 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
1.94 | 2.33 | — | 3.24 | 3.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
30.74 | 45.04 | — | 231.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
192.62 | 133.63 | — | 112.55 | 112.55 | 112.55 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1.05 | 1.48 | 1.11 | 0.75 | 0.75 | 39.37 | 78.00 | 72.00 | 66.00 | 73.50 |
Average Payables |
0.02 | 0.11 | — | — | — | — | — | — | — | — |
Average Inventory |
0.07 | 0.08 | — | 0.10 | 0.10 | — | — | — | — | — |
Average Assets |
4.52 | 2.29 | 1.88 | 2.26 | 2.26 | 906.63 | 1,811.00 | 2,493.00 | 3,175.00 | 3,408.50 |
Average Common Equity |
2.75 | 1.26 | — | 0.45 | (0.11) | (1.55) | (3.00) | 105.50 | 214.00 | 315.00 |
Columns are period end dates